**Core tip:** Our meta-analysis of more than 5000 patients demonstrates that when compared to traditional colonoscopy, the use of an Endocuff device improves adenoma detection rates without any adverse effect on procedural efficiency or increased risk of significant adverse events.

INTRODUCTION
============

Colorectal cancer is one of the most frequently occurring tumors in the industrialized world\[[@B1],[@B2]\]. One unique benefit of colonoscopy over other noninvasive methods of cancer screening is the potential to not only diagnose precancerous adenomatous polyps, but also to remove them endoscopically and thereby reduce colorectal cancer morbidity and mortality\[[@B3]\]. However, even with excellent colonoscopic technique, some poorly visualized areas of the colon, such as behind folds and at the inner curves of flexures, can be difficult to examine. On tandem colonoscopy studies, adenoma miss rates as high as 27% have been reported\[[@B4]\], and subsequent population-based studies have revealed an interval cancer rate after colonoscopy as high as 3%-8%\[[@B5],[@B6]\]. Investigation has revealed that the adenoma detection rate (ADR), the proportion of one provider's colonoscopies during which at least one adenoma can be detected, correlates inversely a patient's risk of developing an interval cancer\[[@B7],[@B8]\]. These findings have led to intense interest in using ADR as a measure of colonoscopy quality.

Another recent area of interest is the observation that the majority of interval cancers are right-sided\[[@B9]\] possibly from missed right-sided sessile serrated adenomas (SSAs)\[[@B10]\]. Through the microsatellite instability pathway, such polyps have been shown to carry a significant risk of progression to malignant change\[[@B11]\]. However, SSAs are known to have traditionally indiscriminate borders and similar endoscopic appearance to other benign colorectal lesions, representing a particular challenge for the endoscopist.

A number of endoscopic devices have been developed in an effort to improve colonoscopic polyp detection and subsequent removal. One such device, the EC (Arc Medical Design Ltd., Leeds, England), is a cap designed to be affixed to the colonoscope head and is comprised of soft projections which remain flattened during insertion and project out, on withdrawal, to spread out the colonic folds. Early experience with the EC suggested that it improved visualization, appeared to have improved polyp detection and facilitated polypectomy\[[@B12]\].

A number of studies have been published comparing the efficacy of EC-assisted colonoscopy (EAC) to that of standard colonoscopy. We performed a meta-analysis of these studies, with a particular interest in adenoma detection, SSA detection, right-sided polyp detection, and other performance characteristics including cecal intubation and complication rates in order to quantitatively summarize the safety and efficacy of EAC.

MATERIALS AND METHODS
=====================

Literature search
-----------------

A three-point systematic and comprehensive literature search was performed on multiple databases. First, Scopus, Cochrane databases, MEDLINE/PubMed, and CINAHL were searched in April 2016. Search terms were "Endocuff", "Endocuff and colonoscopy", "Endocuff and adenoma detection", and "Endocuff and polyp detection". Second, abstracts from Digestive Disease Week, United European Gastroenterology, and the American College of Gastroenterology meeting were searched from 2004-2015 using the same terms. Third, all the references from the reviewed articles were searched for any other articles that may have been missed. Authors were contacted if the data needed clarification or were not complete.

Data extraction
---------------

Studies on adult patients undergoing colonoscopy that compared EAC to standard colonoscopy were included. Two reviewers (Chin M and Nguyen DL) searched the articles and extracted the data independently with any disagreements being settled by a third party (Bechtold ML) or consensus decision.

Study quality assessment
------------------------

The quality of studies was assessed using the Effective Public Health Practice Project model. This scale assesses study quality as strong, moderate, or weak based upon criteria ratings for selection bias, study design, confounders, blinding, data collection methods, withdrawal and dropout descriptions, intervention integrity, and analysis. The quality of the study is based upon the number of weak ratings per category (≥ 2 wk ratings = weak, one weak rating = moderate, and no weak rating = strong).

Statistical analysis
--------------------

A meta-analysis was performed between EAC compared to the standard colonoscopy. Pooled estimates analyses were conducted for ADR, SSA detection rate, right-sided polyp detection, and cecal intubation. Results were presented as odds ratio (OR) using the Mantel-Haenszel fixed effect model in outcomes with no heterogeneity, and the DerSimonian and Laird, the random effects model in outcomes with significant heterogeneity. The *I*^2^ measure of inconsistency (*P \<* 0.10 or *I*^2^ \> 50% was significant) was utilized to assess heterogeneity. If statistically significant heterogeneity was identified, the results underwent a separate sensitivity analysis. This analysis removed specific studies and re-examined outcome results for continued heterogeneity. RevMan 5.3 (Review Manager, Version 5.3, Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012) was used for statistical analysis. Funnel plots were analyzed for presence of publication bias. A biomedical statistician familiar with the study design performed statistical review.

RESULTS
=======

Study selection
---------------

The initial literature search yielded 93 articles and abstracts (Figure [1](#F1){ref-type="fig"}). Of the 93 articles, 71 were excluded because they were in a foreign language, duplicates, or did not involve colonoscopy examinations. Of the remaining 22 potentially appropriate articles and abstracts, 13, were excluded due to the lack of a comparison group, the use of the device in an anatomic model, or for being reviews or editorial comments. A total of 9 studies comparing EAC with conventional colonoscopy were included in the final analysis.
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Study details
-------------

Of the nine included comparative studies\[[@B13]-[@B21]\], summarized in Table [1](#T1){ref-type="table"}, four were retrospective cohort studies, four were prospective randomized controlled trials, and one was a prospective observational study. Indications for colonoscopy varied across the index study including average risk screening, high risk screening due to family history, surveillance due to history of previous polyps, follow up for positive stool testing (FOBT or FIT), and diagnostic procedures for concerning symptoms including pain, changes in quality of stools, anemia, or hematochezia. Exclusion criteria also varied across the studies including history of recurrent diverticulitis, colonic stricture, or previous colonic surgery. All studies included procedures performed at academic hospitals with the exception of Shah-Ghassemzadeh et al\[[@B18]\], which indexed patients at VA hospital, and Cattau et al\[[@B19]\], which included procedures performed in a community settings.

###### 

Study details

  **Ref**.                          **Study design**                          **Location**        **Practice setting**            **Study period**       **Procedure Indication**                                 **Number patients**   **Gender**         **Age (yr)**   **Primary outcome**     **ADR EAC standard**   **EAC Complications**   **Cecal intubation rate/time EAC standard**
  --------------------------------- ----------------------------------------- ------------------- ------------------------------- ---------------------- -------------------------------------------------------- --------------------- ------------------ -------------- ----------------------- ---------------------- ----------------------- ---------------------------------------------
  Marsano et al\[[@B13]\] 2014      Retrospective chart review                New York            Academic, community             9/13-11/13             Screening, surveillance                                  318                   NR                 NR             ADR                     47%                    NR                      NR/NR
  30%                               NR/NR                                                                                                                                                                                                                                                                                                        
  Biecker et al\[[@B14]\] 2015      Randomized prospective 2-center RCT       Germany             Academic                        2/13-8/13              Screening, surveillance, diagnostic                      498                   249 male (50%)     67 (56-75),    Polyps/procedure        35%                    Mucosal injury (9)      98%/NR
  249 female (50%)                  Median (IQR)                              27%                 Loss of cuff (6)                98%/NR                                                                                                                                                                                                         
  Floer et al\[[@B15]\] 2014        Randomized prospective 4-center RCT       Germany             Academic                        2/14-7/14              Screening, surveillance, diagnostic                      492                   231 male (47%)     64 (54-73),    ADR                     35%                    Mucosal injury (18)     96%/NR
  261 female (53%)                  Median (IQR)                              21%                 94%/NR                                                                                                                                                                                                                                         
  Tsiamoulos et al\[[@B16]\] 2015   Prospective observational single center   United Kingdom      Academic                        4/13-9/14              Screening                                                399                   NR                 NR             ADR                     69%                    Elective removal (1)    NR/7.5 min (mean)
  58%                               Discomfort (1)                            NR/9.5 min (mean)                                                                                                                                                                                                                                                  
  van Doorn et al\[[@B17]\] 2015    Randomized prospective 5-center RCT       Netherlands         Academic                        8/13-10/14             Surveillance, FIT positive, family history, diagnostic   1063                  549 Male (51.6%)   65,            Adenomas/patient, ADR   54%                    Elective removal (22)   98%/7 min (median)
  514 Female (48.4%)                Median                                    53%                 Post-polypectomy bleeding (2)   99%/8.3 min (median)                                                                                                                                                                                           
                                                                                                  Thromboembolic event (1)                                                                                                                                                                                                                       
  Shah et al\[[@B18]\] 2015         Retrospective chart review                California          Veterans Affair's Hospital      1/14-2/15              Screening, diagnostic                                    449                   417 male (92.9%)   NR             ADR, SSADR              62%                    NR                      NR/NR
  32 female (7.1%)                  49%                                       NR/NR                                                                                                                                                                                                                                                              
  Cattau et al\[[@B19]\] 2015       Prospective randomized multi center RCT   Tennessee           Community                       NR                     Screening                                                658                   317 male (48.2%)   58 ± 8,        ADR                     50%                    NR                      99%/NR
  341 female (51.8%)                mean ± SD                                 46%                 98%/NR                                                                                                                                                                                                                                         
  Grewal et al\[[@B20]\] 2015       Retrospective chart review                California          Academic                        8/14-5/15              Screening, surveillance, diagnostic                      1237                  595 male (48.1%)   61 (54-69)     SSADR                   NR                     NR                      NR/NR
  642 female (51.9%)                Median (IQR)                              NR/NR                                                                                                                                                                                                                                                              
  Chin et al\[[@B21]\] 2015         Retrospective chart review                California          Academic                        8/14-5/15              Screening                                                510                   234 male (45.9%)   57 (52-61),    ADR                     56%                    NR                      99%/12 min (mean)
  276 female (54.1%)                Median (IQR)                              45%                 97%/11 min (mean)                                                                                                                                                                                                                              

ADR: Adenoma detection rate; EAC: Endocuff assisted colonoscopy; FIT: Fecal immunohistochemical testing; IQR: Interquartile range; NR: Not reported; RCT: Randomized, controlled trial; SSADR: Sessile serrated adenoma detection rate.

Cecal intubation
----------------

There were three studies that evaluated the cecal intubation time\[[@B16],[@B17],[@B21]\] (Table [1](#T1){ref-type="table"}). The reported average cecal intubation times between the EC group were relatively similar to the standard colonoscopy group, with EC group being between 7.0 to 11.7 min compared to 8.3 to 10.7 min in the standard colonoscopy group. In the pooled analysis of four of the nine studies (*n* = 1899) that evaluated the cecal intubation rate (Figure [2](#F2){ref-type="fig"})\[[@B14],[@B15],[@B19],[@B21]\], the results were similar between the EC group compared to the standard colonoscopy group (OR = 1.26 95%CI: 0.70-2.27, *I*^2^ = 0%; *P =* 0.44).
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Adenoma detection rate
----------------------

Of the nine studies included in the analysis, eight (*n =* 4387) reported ADR as an outcome (Figure [3](#F3){ref-type="fig"})\[[@B13]-[@B19],[@B21]\]. Overall, there was a higher ADR in the EC group of 50.4% compared to the standard colonoscopy group of 43.3% (OR = 1.49 95%CI: 1.23-1.80, *I*^2^ = 55%; *P =* 0.03). The number of procedures needed to be performed with EC in order to yield one additional procedure with an adenoma was 14. Given the significant heterogeneity, we performed a sensitivity analysis through exclusion of the Floer et al\[[@B15]\] study because it reported the lowest adenoma detection amongst the studies. Results remained statistically significant, favoring higher adenoma detection rate in the EC group compared to the standard colonoscopy (OR = 1.42 95%CI: 1.18-1.72, *I*^2^ = 50%, *P* \< 0.01). Furthermore, if only indexing randomized control trials in the meta-analysis\[[@B14],[@B15],[@B17],[@B19]\] there remains statistically significant higher adenoma detection rate in the EC compared to the standard colonoscopy group (OR = 1.33 95%CI: 1.01-1.76; *I*^2^ = 66%, *P =* 0.03).
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Right-sided polyp detection rate
--------------------------------

A total of three studies\[[@B13],[@B14],[@B20]\] (*n =* 1326) evaluated the right-sided polyp detection rate using the EC compared to the standard colonoscopy. Overall, there was an enhanced rate of detection of right-sided colonic polyps in the EC group of 33.4% compared to 24.0% (OR = 1.63, 95%CI: 1.28-2.08, *I*^2^ = 0%; *P \<* 0.001) (Figure [4](#F4){ref-type="fig"}).
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Sessile serrated adenoma detection rate
---------------------------------------

Two studies\[[@B18],[@B20]\] (*n =* 1686) evaluated SSA detection rates with EC compared to standard colonoscopy. There was a higher SSA detection rate in the EAC group of 11.6% compared to the standard colonoscopy of 5.6% (OR = 2.34, 95%CI: 1.63-3.36; *I*^2^ = 52%; *P \<* 0.001) (Figure [5](#F5){ref-type="fig"}). The number of procedures needed to be performed with EC in order to yield one additional procedure with a sessile serrated adenoma was 17.

![Sessile serrated adenoma detection.](WJG-22-9642-g005){#F5}

Complication rate
-----------------

Four studies (*n =* 2452) reported complication rates\[[@B14]-[@B17]\]. The complication rate was higher in the EAC group than the standard colonoscopy group (5.47% *vs* 0.61%, *P \<* 0.001). The most commonly reported complication was clinically insignificant superficial mucosal injury, which was reported in 27 patients in the EC group (2.3%). A total of 23 patients (2.0%) in the EC group required removal of the device due to patient discomfort and the procedure was then successfully completed without the EC. The next most common complication was the loss of the device, and subsequent retrieval, on withdrawal, reported in only one study, occurring in 6 (0.52%) EC patients. No perforations were reported in the EC group.

DISCUSSION
==========

Colonoscopy with adenoma detection and removal is widely considered the gold standard for the prevention of colorectal cancer, but is limited by an adenoma miss rate as high as 27%\[[@B4]\]. In an effort to increase the effectiveness of colonoscopy, recent interest has evolved around the development of a variety of techniques and devices to improve our ability to examine areas of the colon that are difficult to see including behind folds and turns.

Our meta-analysis of nine comparative studies on one such device, the EC showed benefit over conventional colonoscopy. Strengths of our analysis include variety of clinical settings, including multi-national academic and community settings and, wide variety of patient populations, in which the EC device was shown to improve polyp detection. In particular, EAC was associated with improved adenoma detection. Other benefits were also appreciated in the EAC group when analyzing right-sided adenoma detection and SSA detection.

One concern regarding the use of the EC is that the device may limit cecal intubation in those patients with traditionally difficult anatomy such as angulation, diverticulosis, or previous abdominal surgery, but only 2% of patients required the removal of the EC device due to technical difficulty in studies reporting such events. The procedures were subsequently completed with a standard colonoscope in all patients. The use of an EC did not effect cecal intubation rate or procedure time. Reported complications were minimal and similar to early observational studies of the device and were limited largely to superficial mucosal trauma\[[@B12],[@B22]\]. However, some studies excluded patients with previous abdominal surgery, history of colonic stricture, or recent diverticulitis, *i.e*., those in whom Endocuff might be more difficult to use in. Furthermore, the retrospective, non-randomized nature of many of the included studies makes it difficult to exclude the possibility that providers may have preferentially performed standard colonoscopy in those with perceived difficult anatomy.

Our study has several limitations and revealed some unanswered questions regarding the potential benefit of EAC over standard colonoscopy. The variability of study designs and outcome measures in this analysis resulted significant heterogeneity. Only English-language studies were included in the analysis, which may introduce publication bias. None of the included studies were performed in tandem fashion, making it difficult to draw conclusions on the incremental benefit of EAC over standard colonoscopy, especially in standard-risk verses high-risk population. While some studies reported whether the EC needed to be removed due to patient discomfort\[[@B16],[@B17]\], no one provided quantified data on patient comfort, or requirement for increased sedation. Our pooled analysis showed the number needed to treat of 14 to achieve one additional adenoma-positive procedure but whether EAC is cost effective or not remains to be determined. The included studies include a heterogeneous list of indications for colonoscopy, which makes conclusions regarding the efficacy of routine EC use on screening colonoscopy somewhat difficult to reach. Finally, bowel prep quality is known to be associated with improved colonoscopy quality\[[@B23]\], yet this important variable was incompletely reported in the included studies, and could confound polyp detection rates, procedural efficiency and safety.

A transparent cap has been used most often prior to the Endocuff to improve polyp detection on colonoscopy. Although it is supposed to improve visualization, the benefit appears to such devices has proven to be modest, with one recent meta-analysis of 16 studies showing a relative risk of 1.08 for polyp detection and a second analysis of 12 studies demonstrating an odds ratio of 1.13\[[@B24],[@B25]\] for cap assisted over standard colonoscopy. The finger-like projections of the Endocuff™ could be better at spreading out the folds to improve detection of polyps explaining the more robust odds ratio for adenoma detection with EAC of 1.49 in our study.

There are several other recently developed accessories that functionally provide the same benefit of spreading folds and affixing the colonoscope in the lumen. These include the EndoRing™ (Endo-Aid, Caesarea, Israel), which is comprised of several clear rings on a cuff designed to be affixed to the colonoscope tip, or the G-Eye™ system (Smart Medical Systems Ltd, Ra-anana, Israel), a novel colonoscope with a balloon integrated at the scope tip that is designed to be inflated upon withdrawal. Several small preliminary studies comparing the EndoRing™ and G-Eye™ system to conventional colonoscopy do suggest some benefit to adenoma detection with such devices\[[@B26]-[@B28]\], but clinical data are relatively scant when compared to the Endocuff™. Furthermore, the G-Eye™ system is not yet commercially approved for use in the United States.

In conclusion, EAC improves adenoma detection without any significant adverse effect on procedural efficiency. Further prospective randomized trials or cost-effectiveness studies of an approach of using the Endocuff on routine screening colonoscopy would be warranted.

COMMENTS
========

Background
----------

Polyp detection rates are used as a correlate for colonoscopy quality. The Endocuff is a recently developed device that has been shown is multiple trials to improve the polyp detection.

Research frontiers
------------------

The development of attachable or integrated colonoscopy devices to improve polyp detection represents one innovation in improving polyp detection and colorectal cancer prevention.

Innovations and breakthroughs
-----------------------------

Multiple small studies have demonstrated that the Endocuff can improve polyp detection, however, there have been no previously published efforts to analyze the aggregated data as a whole of such studies.

Applications
------------

The results of this study can form the basis for future development of colonoscopy-assist devices and inform a physician's decision to utilize such a device.

Terminology
-----------

Endocuff: a novel cap affixed to the colonoscope head comprised of soft projections that remain flattened during insertion and project out on withdrawal to spread out the colonic folds
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